A New Drug Combinatory Effect Prediction Algorithm on the Cancer Cell Based on Gene Expression and Dose-Response
C Pankaj Goswami1, L Cheng2, P S Alexander3
1Molecular Lab, Thomas Jefferson University Hospitals Philadelphia, Pennsylvania, USA.
Abstract:
Gene expression data before and after treatment with an individual drug and the IC20 of dose-response data were utilized to predict two drugs' interaction effects on a diffuse large B-cell lymphoma (DLBCL) cancer cell. A novel drug interaction scoring algorithm was developed to account for either synergistic or antagonistic effects between drug combinations. Different core gene selection schemes were investigated, which included the whole gene set, the drug-sensitive gene set, the drug-sensitive minus drug-resistant gene set, and the known drug target gene set. The prediction scores were compared with the observed drug interaction data at 6, 12, and 24 hours with a probability concordance (PC) index. The test result shows the concordance between observed and predicted drug interaction ranking reaches a PC index of 0.605. The scoring reliability and efficiency was further confirmed in five drug interaction studies published in the GEO database.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Dose-Response Relationship: Overview
Dose Response Curve: Conventional Versus Nonmonotonic
Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Cancer Survival Analysis


